Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 11, 2004 - Issue 5-6
17
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Differential Toxicity of Anthracyclines on Cultured Endothelial Cells

, &
Pages 253-258 | Published online: 13 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Arzu Okur, Ceyda Karadeniz, Suna Özhan Oktar, Faruk Güçlü Pınarlı, Arzu Aral & Aynur Oğuz. (2016) Assessment of brachial artery reactivity, carotid intima-media thickness, and adhesion molecules in pediatric solid tumor patients treated with anthracyclines. Pediatric Hematology and Oncology 33:3, pages 178-185.
Read now

Articles from other publishers (21)

Janée D. Terwoord, Andreas M. Beyer & David D. Gutterman. (2022) Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacology & Therapeutics 237, pages 108116.
Crossref
Sofiane Fodil, Marine Arnaud, Camille Vaganay, Alexandre Puissant, Etienne Lengline, Nuala Mooney, Raphael Itzykson & Lara Zafrani. (2022) Endothelial cells: major players in acute myeloid leukaemia. Blood Reviews 54, pages 100932.
Crossref
Miriam Durante, Maria Frosini, Fabio Fusi, Alessandra Gamberucci, Konstantin Chegaev, Barbara Rolando, Chiara Riganti, Roberta Fruttero & Simona Saponara. (2020) In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicin. European Journal of Pharmacology 880, pages 173164.
Crossref
Haichen Lv, Ruopeng Tan, Jiawei Liao, Zhujing Hao, Xiaolei Yang, Yang Liu & Yunlong Xia. (2020) Doxorubicin contributes to thrombus formation and vascular injury by interfering with platelet function. American Journal of Physiology-Heart and Circulatory Physiology 319:1, pages H133-H143.
Crossref
Valentina Mercurio, Giulio Agnetti, Pasquale Pagliaro & Carlo G. Tocchetti. 2019. Cardiovascular Complications in Cancer Therapy. Cardiovascular Complications in Cancer Therapy 3 14 .
Vivian Wing-yi Li, Anthony Pak-yin Liu, Karin Kar-Huen Ho, Jeffrey Ping-Wa Yau, Daniel Ka-leung Cheuk & Yiu-fai Cheung. (2018) Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers. Cardio-Oncology 4:1.
Crossref
Canan G. Nebigil & Laurent Désaubry. (2018) Updates in Anthracycline-Mediated Cardiotoxicity. Frontiers in Pharmacology 9.
Crossref
Álvaro Caballero Romero, María Teresa Delgado Ureña, Antonio Salmerón García, María Teresa Megías Fernández, María Librada Porriño-Bustamante & José Cabeza Barrera. (2018) Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane. Anti-Cancer Drugs 29:9, pages 821-826.
Crossref
Lucia Morbidelli, Sandra Donnini & Marina Ziche. (2016) Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents. Cardio-Oncology 2:1.
Crossref
Lijuan Kan, Aubrie Smith, Miao Chen, Benjamin T. Ledford, Huimin Fan, Zhongmin Liu & Jia-Qiang He. (2015) Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells. PLOS ONE 10:12, pages e0144513.
Crossref
Tomasz Wojcik, Ewa Szczesny & Stefan Chlopicki. (2015) Detrimental effects of chemotherapeutics and other drugs on the endothelium: A call for endothelial toxicity profiling. Pharmacological Reports 67:4, pages 811-817.
Crossref
Tomasz Wojcik, Elzbieta Buczek, Katarzyna Majzner, Agnieszka Kolodziejczyk, Justyna Miszczyk, Patrycja Kaczara, Wojciech Kwiatek, Malgorzata Baranska, Marek Szymonski & Stefan Chlopicki. (2015) Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells. Toxicology in Vitro 29:3, pages 512-521.
Crossref
Biljana Ristic, Mihajlo Bosnjak, Katarina Arsikin, Aleksandar Mircic, Violeta Suzin-Zivkovic, Andrija Bogdanovic, Vladimir Perovic, Tamara Martinovic, Tamara Kravic-Stevovic, Vladimir Bumbasirevic, Vladimir Trajkovic & Ljubica Harhaji-Trajkovic. (2014) Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells. Experimental Cell Research 326:1, pages 90-102.
Crossref
Irit Ben Aharon, Hadas Bar Joseph, Moran Tzabari, Boris Shenkman, Nahid Farzam, Mattan Levi, Ruth Shalgi, Salomon M. Stemmer & Naphtali Savion. (2013) Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity. PLoS ONE 8:9, pages e75157.
Crossref
Yu. V. Azizova, D. L. Teplyi, E. D. Bazhanova & O. N. Pozdnyakova. (2012) The effect of water deprivation and α-tocopherol acetate on the expression of apoptosis marker proteins. Advances in Gerontology 2:1, pages 38-42.
Crossref
Hadas Bar-Joseph, Irit Ben-Aharon, Moran Tzabari, Galia Tsarfaty, Salomon M. Stemmer & Ruth Shalgi. (2011) In vivo Bioimaging as a Novel Strategy to Detect Doxorubicin-Induced Damage to Gonadal Blood Vessels. PLoS ONE 6:9, pages e23492.
Crossref
Katalin Keltai, László Cervenak, Veronika Makó, Zoltán Doleschall, András Zsáry & István Karádi. (2010) Doxorubicin selectively suppresses mRNA expression and production of endothelin-1 in endothelial cells. Vascular Pharmacology 53:5-6, pages 209-214.
Crossref
M. Vassilakopoulou, G. Mountzios, C. Papamechael, A.D. Protogerou, K. Aznaouridis, P. Katsichti, K. Venetsanou, M.-A. Dimopoulos, I. Ikonomidis & C.A. Papadimitriou. (2010) Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrate-mediated vasodilatation. Vascular Pharmacology 53:3-4, pages 115-121.
Crossref
Elias Gyftodimos, Laura Moss, Derek Sleeman & Andrew Welch. 2008. Applications and Innovations in Intelligent Systems XV. Applications and Innovations in Intelligent Systems XV 59 72 .
Ewa Gajewski, Shikha Gaur, Steven A. Akman, Linda Matsumoto, Josephus N.A. van Balgooy & James H. Doroshow. (2007) Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin. Biochemical Pharmacology 73:12, pages 1947-1956.
Crossref
Garry M. McDermott, Andrew Welch, Roger T. Staff, Fiona J. Gilbert, Lutz Schweiger, Scott I. K. Semple, Tim A. D. Smith, Andrew W. Hutcheon, Iain D. Miller, Ian C. Smith & Steven D. Heys. (2006) Monitoring primary breast cancer throughout chemotherapy using FDG-PET. Breast Cancer Research and Treatment 102:1, pages 75-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.